We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Toujeo Support Screenshots

About Toujeo Support

Toujeosupport app has been developed to support treatment with Toujeo

Your doctor has prescribed Toujeo for you.

Toujeo is a long-acting insulin for the treatment of adults with type 1 and 2 diabetes for the control of high blood glucose.

The Toujeosupport app is an initiative of Sanofi. The Toujeosupport app has been developed to support you in treatment with Toujeo.

It contains tools such as the injection tracker, carbohydrate counter, pedometer and frequently asked questions about Toujeo.

You can also keep track of what and how much you ate in a day. The pedometer is displayed on the same screen; this shows up-to-date how much you still have to burn.

Download the app and discover what the Toujeosupport app can do for you. The app can be activated with the EU code on the Toujeo package or with the code that you have received from your healthcare provider.

Unlock the new functions and experience even more ease of use with the Toujeosupport app.

If you have any questions about your treatment with Toujeo, contact your doctor. The Toujeosupport app is not a medical device or diagnostic tool and no therapeutic value can be derived from it.

What's New in the Latest Version 2.4.1

Last updated on Jan 11, 2021

Scherm, afbeeldingen en navigatie verbeteringen.

Translation Loading...

Additional APP Information

Latest Version

Request Toujeo Support Update 2.4.1

Uploaded by

Zkoor Mohamed

Requires Android

Android 4.3+

Show More
Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.